STAR Protocols (Dec 2024)

Protocol for sorting cancer stem cells using a combination of anti-CD133 antibody and lectin cyanovirin-N

  • Yuanyan Wei,
  • Shuting Geng,
  • Qihang Chen,
  • Jiayue Chen,
  • Zhijun Fan,
  • Yi Li,
  • Yu Si,
  • Yuerong Yang,
  • Ziwei Liang,
  • Jianhai Jiang

Journal volume & issue
Vol. 5, no. 4
p. 103443

Abstract

Read online

Summary: CD133 is widely used as a marker to isolate cancer stem cells (CSCs). However, the structural ambiguity of N-glycan of CD133 limits its application in the isolation of CSCs. Here, we present a protocol to sort CSCs from tumor samples by combining CD133 with α-1,2-high-mannose type glycan chains. We describe steps for purifying and biotinylating cyanovirin-N (CVN) proteins and sorting tumor cells and CD133+α-1,2-Man+ (α-1,2-linked mannose+) cells to provide more specific markers for CSCs.For complete details on the use and execution of this protocol, please refer to Wei et al.1 : Publisher’s note: Undertaking any experimental protocol requires adherence to local institutional guidelines for laboratory safety and ethics.

Keywords